Stay updated on KarXT for Alzheimer's Psychosis Clinical Trial
Sign up to get notified when there's something new on the KarXT for Alzheimer's Psychosis Clinical Trial page.

Latest updates to the KarXT for Alzheimer's Psychosis Clinical Trial page
- CheckyesterdayChange Detected- The page reflects a new administrative update cycle, adjusting the shown posted/verification timestamps and associated status. - The site revision/version string changes from `Revision: v3.5.2` to `Revision: v3.5.3`, indicating a page/content system update rather than a study-content change.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision tag updated to v3.5.2; the previous revision tag v3.5.0 was removed.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedUpdated the study record to add sponsor details (Karuna Therapeutics, Inc.), update primary and secondary objectives, include EU CTR and other IDs, and expand site contacts and investigators. Added IPD sharing information and links to the protocol, SAP, CSR, and related documents.SummaryDifference4%

- Check37 days agoChange DetectedPage revision updated to v3.5.0. The previous revision v3.4.3 was removed.SummaryDifference0.0%

- Check44 days agoChange Detected- Removed the sponsor line "Karuna Therapeutics, Inc., a Bristol Myers Squibb company" and the "Collaborators" section from the Study Details page.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to KarXT for Alzheimer's Psychosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT for Alzheimer's Psychosis Clinical Trial page.